跳至主要内容
临床试验/NCT02411318
NCT02411318已完成不适用

Influence of Lifestyle Factors on Neutrophil Migration Pilot Study

University of Wisconsin, Madison1 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2014年9月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
47
试验地点
1
主要终点
Change in Caffeine-Related Neutrophil Chemotactic Velocity

研究概览

简要总结

This study will determine how common lifestyle practices affect the behavior of neutrophils (a type of immune cell) at shorter time scales than previously possible.

详细描述

This study will investigate how external factors implicated in immunity such as exercise, caffeine ingestion, ethanol, glucose, and glucose and caffeine ingestion influence neutrophil migration.

Neutrophils are the most prominent immune cell in human blood and are involved in a complex equilibrium of immune protection and autoimmune damage. Their recruitment to an inflammatory or wounding site is controlled by the sensing and directed migration to a concentration gradient of attractant molecules, a process called chemotaxis. Immune cells are also implicated in many diseases including cancer. The ability to measure the amplitude of a response over time for a specific patient, and the variation of this response when the patient engages in certain activities or consumes certain substances will improve understanding of how certain lifestyle factors impact the immune response. Traditional assays require large volumes of blood and a long purification process, which may affect neutrophil function and strictly limits the number of draws possible from a single patient. The novel microfluidic assay proposed limits these drawbacks as it has the capability to purify neutrophils from a 3 µL drop of blood in less than 5 minutes and measure their chemotaxis in a gradient of chemokines. Critically, the proposed studies will begin to fill a gap in current understanding of immune response as previous studies focused on single endpoints likely missing early events in the response to external stimulus. Understanding this temporal response may have implications in the development of new treatments as well as improvements in diagnosis of improper immune response.

The KOALA (Kit On A Lid Assay) approach was developed in Professor Dave Beebe's lab and has been validated in a mouse model and in human asthmatic patients. In a collaboration with Dr. Anna Huttenlocher, it has been shown that, in contrast to traditional neutrophil purification, KOALA can be performed with small volumes of blood, and a much quicker purification time.

Due to its unique qualities, KOALA allows for repeated evaluation of neutrophil adhesion and chemotaxis properties, thus making it an attractive method for studying dynamic neutrophil changes that may occur as a result of an external factor.

Using traditional macrobiology tools, researchers have identified several factors that may play important roles in reducing neutrophil responsiveness and migration ability. Lifestyle and diet factors, amongst others, have been shown to impact neutrophil count, migration and biochemical function. For example, sleep deprivation has been linked with higher neutrophil count, despite a known immuno-depressive effect. Physical exercise results in increased neutrophil counts and increased neutrophil degranulation. Dietary factors, such as caffeine and ethanol have been shown to impact immune function.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
21 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Capacity to provide informed consent and ability to speak and read English.
  • •Male or female with no chronic or acute health concerns that might affect subject safety during the study or interfere with the study results
  • •No intake of medication that the researchers believe will significantly influence immune function in the 48 hours proceeding the lancet puncture (examples given in the section entitled "Exclusion Criteria")
  • •In good physical health
  • •Regularly exercise at least 30 minutes 3 times per week (exercise cohort)

排除标准

  • •Currently participating in another clinical trial
  • •History of significant systemic disease (eg. cancer, infection, hematological, renal, hepatic, coronary artery disease or other cardiovascular disease, endocrinologic, neurologic, rheumatologic, or gastrointestinal disease)
  • •Use of beta blockers or corticosteroids
  • •Currently taking medications that are not recommended to be taken in conjunction with alcohol
  • •Acute illness or evidence of clinically significant active infection
  • •Currently receiving immunotherapy
  • •Pregnant women
  • •Ingested medication (e.g. systemic corticosteroids) within 48 hours preceding the draw that the researchers believe may have an effect on immune response or the immune system
  • •Performed any activity that conflicts (eg. drinking any alcohol prior to the study), in the judgment of the investigator, with the external factor to be tested in the study (if any)
  • •Alcoholic or other health conditions for which alcohol consumption is contraindicated
  • •Consume more than 7 drinks per week (women alcohol cohort)
  • •Consume more than 14 drinks per week (men alcohol cohort)
  • •Consume more than three (8 oz.) servings of coffee, caffeinated soft drinks/tea (12 oz.) per day (caffeine cohort)

研究组 & 干预措施

Cardiovascular Exercise

Experimental

Participants will ride a stationary bike and maintain their target heart rate (according to the American Heart Association guidelines) for 30 minutes. For example, a 30 year old will have a target heart rate zone of 95-162 beats per minute. A baseline blood sample will be acquired before the participant begins exercising. In the following 30 minutes, participants will ride the exercise bike, and their heart rate and general status will be assessed continuously. Specifically, heart rate will be monitored using a chest strap heart rate monitor. Two additional lancet punctures will be performed after the exercise to measure the changes in neutrophil function: one immediately following the 30 minute exercise period and one 30 minutes after the exercise has been completed.

干预措施: Exercise (Behavioral)

Caffeine Consumption

Experimental

Participants will be exposed to a moderate dose of caffeine (200 mg capsule in one sitting) from a common commercial product. After consent and screening, a baseline blood sample will be acquired using the lancet puncture procedure. The participant will then be instructed to swallow a 200 mg caffeine capsule. Two additional lancet punctures will be performed after the caffeine ingestion: one after 30 minutes post-ingestion and another one after 60 minutes.

干预措施: ProLab 200mg caffeine capsule (Drug)

Glucose and Caffeine Ingestion

Experimental

After a baseline blood sample is acquired, participants will swallow 200mg of caffeine in capsule form and consume 100 grams of glucose within 5 minutes. Two additional lancet punctures will be performed after the caffeine and glucose ingestion, one at 30 minutes post-ingestion, and one at 60 minutes post-ingestion.

干预措施: ProLab 200mg caffeine capsule (Drug)

Ethanol Ingestion

Experimental

Participants will be weighed and their required alcohol dose determined according to the equation used by the Madison Police Department during alcohol training workshops: 1 mL of 80 proof (40%) alcohol per pound of body weight. Participants will be permitted to consume the drink at their own pace, although no slower than one drink per hour. Breath Alcohol Concentration (BAC) will be tested 20 minutes after drinking has ceased in order to clear mouth alcohol that may affect the BAC reading. Participants at 0.05 BAC and above will have blood drawn via lancet puncture. In addition to the lancet puncture done once the alcohol level is reached, an additional lancet puncture will be performed 1 hour later.

干预措施: Ethanol ingestion (Other)

Glucose Ingestion

Experimental

After a baseline blood sample is acquired, participants will consume 100 grams of glucose within 5 minutes. Two additional lancet punctures will be performed after the glucose ingestion, one at 30 minutes post-ingestion, and one at 60 minutes post-ingestion.

干预措施: Glucose Tolerance Drink (Drug)

Glucose and Caffeine Ingestion

Experimental

After a baseline blood sample is acquired, participants will swallow 200mg of caffeine in capsule form and consume 100 grams of glucose within 5 minutes. Two additional lancet punctures will be performed after the caffeine and glucose ingestion, one at 30 minutes post-ingestion, and one at 60 minutes post-ingestion.

干预措施: Glucose Tolerance Drink (Drug)

结局指标

主要结局

Change in Caffeine-Related Neutrophil Chemotactic Velocity

时间窗: baseline, 30 min, 60 min

Participants will consume a moderate dose of caffeine via 200mg capsule. Blood samples via lancet will be collected at baseline, 30 min (immediately post intervention), and 60 min.

Change in Glucose-Related Neutrophil Chemotactic Velocity

时间窗: baseline, 30 min, 60 min

Participants will consume 100g glucose tolerance drink within 5 minutes. Blood samples via lancet will be collected at baseline, 30 min (immediately post intervention), and 60 min.

Change in Ethanol-Related Neutrophil Chemotactic Velocity

时间窗: baseline, 1-3 hours from baseline, up to 2-4 hours from baseline

Participants will consume a weight-calculated dose of alcohol sufficient to increase their blood alcohol concentration (BAC) to 0.05. Blood samples via lancet will be collected at baseline, 1-3 hours (when BAC reached 0.05) and 1 hour after previous collection.

Change in Exercise-Related Neutrophil Chemotactic Velocity

时间窗: baseline, 30 min, 60 min

Participants will ride a stationary bike and maintain their target heart rate for 30 min. Blood samples via lancet will be collected at baseline, 30 min (immediately post intervention), and 60 min.

Change in Caffeine Plus Glucose-Related Neutrophil Chemotactic Velocity

时间窗: baseline, 30 min, 60 min

Participants will consume a moderate dose of caffeine via 200mg capsule and 100g of glucose tolerance drink within 5 min. Blood samples via lancet will be collected at baseline, 30 min (immediately post intervention), and 60 min.

次要结局

  • Change in Exercise-Related Neutrophil Absolute Speed(baseline, 30 min, 60 min)
  • Change in Glucose-Related Neutrophil Absolute Speed(baseline, 30 min, 60 min)
  • Change in Caffeine Plus Glucose-Related Neutrophil Absolute Speed(baseline, 30 min, 60 min)
  • Change in Exercise-Related Neutrophil Chemotactic Index(baseline, 30 min, 60 min)
  • Change in Caffeine-Related Neutrophil Chemotactic Index(baseline, 30 min, 60 min)
  • Change in Glucose-Related Neutrophil Chemotactic Index(baseline, 30 min, 60 min)
  • Change in Caffeine-Related Neutrophil Absolute Speed(baseline, 30 min, 60 min)
  • Change in Ethanol-Related Neutrophil Absolute Speed(baseline, 1-3 hours from baseline, up to 2-4 hours from baseline)
  • Change in Caffeine Plus Glucose-Related Neutrophil Chemotactic Index(baseline, 30 min, 60 min)
  • Change in Ethanol-Related Neutrophil Chemotactic Index(baseline, 1-3 hours from baseline, up to 2-4 hours from baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Influence of Lifestyle Factors on Neutrophil... | 临床试验